{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:32:49Z","timestamp":1778509969509,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1986]]},"DOI":"10.1007\/bf00606649","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T04:01:56Z","timestamp":1101355316000},"page":"133-141","source":"Crossref","is-referenced-by-count":11,"title":["Antihypertensive efficacy of pinacidil ? Automatic ambulatory blood pressure monitoring"],"prefix":"10.1007","volume":"31","author":[{"given":"P. K.","family":"Zachariah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Sheps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schirger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. D.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Shub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. B.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Spiekerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/jm00206a011","volume":"21","author":"HJ Petersen","year":"1978","unstructured":"Petersen HJ, Nielsen CK, Arrigoni-Martelli E (1978) Synthesis and hypotensive activity ofN-alkyl-N?-cyano-N?-pyridylguanidines. J Med Chem 21: 773?781","journal-title":"J Med Chem"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF01975139","volume":"36","author":"E Arrigoni-Martelli","year":"1980","unstructured":"Arrigoni-Martelli E, Nielsen CK, Olsen UB, Petersen HJ (1980)N?-cyano-N-4-pyridyl-N?-1,2,2-trimethylpropylguanidine monohydrate (P 1134): A new potent vasodilator. Experientia 36: 445?447","journal-title":"Experientia"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1475-097X.1981.tb00905.x","volume":"1","author":"J Carlsen","year":"1981","unstructured":"Carlsen J, Kardel T, Hilden T, Tango M, Trap-Jensen J (1981) Immediate central and peripheral hemodynamic effects of P1134, a new vasodilating agent in hypertensive man. Clin Physiol 1: 375?384","journal-title":"Clin Physiol"},{"key":"CR4","first-page":"229","volume":"33","author":"G Muiesan","year":"1983","unstructured":"Muiesan G, Fariello R, Muiesan ML (1983) Effects of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertensive patients (abstract). Clin Pharmacol Ther 33: 229","journal-title":"Clin Pharmacol Ther"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2125.1983.tb02171.x","volume":"16","author":"LE Ramsey","year":"1983","unstructured":"Ramsey LE, Freestone S (1983) Preliminary evaluation of pinacidil in hypertension. Br J Clin Pharmacol 16: 336?338","journal-title":"Br J Clin Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00543493","volume":"26","author":"JW Ward","year":"1984","unstructured":"Ward JW, McBurney A, Farrow PR, Sharp P (1984) Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil: A new potent vasodilator. Eur J Clin Pharmacol 26: 603?608","journal-title":"Eur J Clin Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00542161","volume":"27","author":"K Koliopoulos","year":"1984","unstructured":"Koliopoulos K, Papadoyannis DE, Karatzas NB (1984) Pinacidil, a new vasodilator, in the treatment of patients with moderate to severe hypertension. Eur J Clin Pharmacol 27: 287?289","journal-title":"Eur J Clin Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF00542128","volume":"25","author":"JE Carlsen","year":"1983","unstructured":"Carlsen JE, Kardel T, Jensen HAE, Tango M, Trap-Jensen J (1983) Pinacidil, a new vasodilator: Pharmacokinetics and pharmacodynamics of a retarded release tablet in essential hypertension. Eur J Clin Pharmacol 25: 557?561","journal-title":"Eur J Clin Pharmacol"},{"key":"CR9","first-page":"1","volume":"1","author":"RT Priest","year":"1979","unstructured":"Priest RT, Weber MA, Brewer DD, Winer RL, Eltorai MI, Wyle FA (Dec 1979) The use of ambulatory blood pressure monitoring to assess the antihypertensive efficacy of captopril (SQ 14, 225) in a patient with treatment-resistant hypertension. Ambulat Electrocardiogr 1: 1?6","journal-title":"Ambulat Electrocardiogr"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/bmj.1.6158.237-a","volume":"1","author":"MW Millar Craig","year":"1979","unstructured":"Millar Craig MW, Kenny D, Mann S, Balasubramanian V, Raftery EB (1979) Effect of once-daily atenolol on ambulatory blood pressure. Br Med J 1: 237?238","journal-title":"Br Med J"},{"issue":"Suppl","key":"CR11","doi-asserted-by":"crossref","first-page":"375s","DOI":"10.1042\/cs057375s","volume":"5","author":"S Mann","year":"1979","unstructured":"Mann S, Millar Craig MW, Altman DG, Melville DI, Raftery EB (1979) The effects of metoprolol on ambulatory blood pressure. Clin Sci 5 [Suppl]: 375s-377s","journal-title":"Clin Sci"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archinte.1985.00360010074010","volume":"145","author":"SG Sheps","year":"1985","unstructured":"Sheps SG, Schirger A, Spiekerman RE, Harman TR, O'Brien PC, Kleven MK, Kremer-Simpson K (1985) Evaluation of pindolol dosage in hypertension by automatic indirect BP monitoring. Arch Intern Med 145: 54?57","journal-title":"Arch Intern Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-3-662-05685-1_28","volume-title":"Ambulatory blood pressure monitoring","author":"SG Sheps","year":"1984","unstructured":"Sheps SG, Schirger A, O'Brien PC, Spiekerman RE, Harman TR (1984) Evaluation of the posology of pindolol therapy of hypertension with automatic indirect ambulatory blood pressure monitoring. In: Weber MA, Drayer JIM (eds) Ambulatory blood pressure monitoring. Springer, New York, 215?220"},{"issue":"Suppl 3","key":"CR14","doi-asserted-by":"crossref","first-page":"575s","DOI":"10.1042\/cs051575s","volume":"51","author":"RC Tarazi","year":"1976","unstructured":"Tarazi RC, Dustan HP, Bravo EL, Niarchos AP (1976) Vasodilating drugs: Contrasting haemodynamic effects. Clin Sci 51 [Suppl 3]: 575s-578s","journal-title":"Clin Sci"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.3.5.580","volume":"3","author":"AMM Shepherd","year":"1981","unstructured":"Shepherd AMM, McNay JL, Ludden TM, Lin M-S, Musgrave GE (1981) Plasma concentration and acetylator phenotype determine response to oral hydralazine. Hypertension 3: 580?585","journal-title":"Hypertension"},{"key":"CR16","first-page":"1190","volume":"39","author":"AMM Shepherd","year":"1980","unstructured":"Shepherd AMM, Musgrave GE, Badke FR, Walsh R (1980) Tachycardia associated with hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazine. (abstract) Fed Proc 39: 1190","journal-title":"Fed Proc"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00562058","volume":"16","author":"DN Bateman","year":"1979","unstructured":"Bateman DN, Hobbs DC, Twomey TM, Stevens EA, Rawlins MD (1979) Prazosin pharmacokinetics and concentration effect. Eur J Clin Pharmacol 16: 177?181","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00606649.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00606649\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00606649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T03:23:46Z","timestamp":1554434626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00606649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986]]}},"alternative-id":["BF00606649"],"URL":"https:\/\/doi.org\/10.1007\/bf00606649","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986]]}}}